Overview
In a changing and expanding world, this is still the only forum designed for QPPVs by QPPVs, now in its 14th year and still going strong.
The QPPV Forum focuses on international QPs’ role and gives a high-level approach to the discussed topics and continues to identify key trends requiring QPPV awareness, input and oversight. This year’s objectives are built on past successes and have been shaped by valuable feedback provided by participants of the past thirteen meetings, plus many years of QPPV and Regulator interaction at this Forum. Moreover, we are looking forward to receiving information and discuss pragmatic approaches on the modern technology and how this will impact the QPPV Role.
This year we will be focusing more on scanning the horizon and check the opportunities and considerations for QPPV role regarding AI, with the hope to demystify AI for QPPV.
Over time, one of the key successes of the Forum has been the ability to secure the continuing support and involvement of key regulators. Sessions have been open and interactive with attendees appreciating opportunities to raise challenging issues in an informal environment. The 14th QPPV Forum continues this successful approach.
Featured
Want to learn more about Global Forum for Qualified Persons for Pharmacovigilance (QPPV)? You've come to the right site!
Program Committee
-
Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom -
Willemijn van der Spuij, MSc Executive Director, WorldWide Patient Safety International, Europe
Switzerland -
Shahinaz Badr Pharmacovigilance Consultant and PVQA Auditor - EMEA
Pharma Quality Europe, United Arab Emirates -
Peter De Veene, MD GQPPV
MSD Belgium, Belgium -
Gemma Jimenez Sese Senior Director, Deputy EU QPPV
AstraZeneca, Spain -
Maarten Lagendijk, MSc Deputy EU QPPV
MSD, Netherlands -
Elspeth McIntosh, MBA, RN Director
Castle Pharmacovigilance Ltd, United Kingdom -
Mette Stockner, MD Senior Pharmacovigilance Director
Savara ApS, Denmark -
Doris Irene Stenver, MD, MPA Independent Pharmacovigilance Adviser
Unique Advice, Denmark -
Katarzyna Swiderek, MPharm, RPh Director, Safety Evaluation Risk Management (SERM)
GlaxoSmithKline, Poland -
Kiernan Trevett, MSc Principal Quality Lead, PDQ Quality Assurance Process GVP
Roche, United States -
Nicolas Tsiakkas, MD Scientific Director
NIKOLAS TSIAKKAS AND CO OE, Greece -
Angela Van Der Salm, PhD, MSc Director PV, Managing partner
DADA Consultancy B.V., Netherlands -
Magnus Ysander, MD EU & UK QPPV & Head Pharmacovigilance Excellence
AstraZeneca, Sweden
Have an account?